The potential of closed circuit lung clearance index (LCI) to provide longitudinal clinical utility in cystic fibrosis (CF).
A. Horsley (Manchester, United Kingdom), A. Alrumuh (Stoke, United Kingdom), K. Bayfield (Manchester, United Kingdom), B. Bianco (Manchester, United Kingdom), S. Cunningham (Edinburgh, United Kingdom), A. Jones (Manchester, United Kingdom), A. Maitra (Manchester, United Kingdom), A. Pandyan (Stoke, United Kingdom), N. Rao (Manchester, United Kingdom), J. Tomlinson (Stoke, United Kingdom), F. Gilchrist (Stoke, United Kingdom), C. Fullwood (Manchester, United Kingdom)
Source: International Congress 2019 – Physiology of cystic fibrosis
Session: Physiology of cystic fibrosis
Session type: Poster Discussion
Number: 332
Disease area: Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Horsley (Manchester, United Kingdom), A. Alrumuh (Stoke, United Kingdom), K. Bayfield (Manchester, United Kingdom), B. Bianco (Manchester, United Kingdom), S. Cunningham (Edinburgh, United Kingdom), A. Jones (Manchester, United Kingdom), A. Maitra (Manchester, United Kingdom), A. Pandyan (Stoke, United Kingdom), N. Rao (Manchester, United Kingdom), J. Tomlinson (Stoke, United Kingdom), F. Gilchrist (Stoke, United Kingdom), C. Fullwood (Manchester, United Kingdom). The potential of closed circuit lung clearance index (LCI) to provide longitudinal clinical utility in cystic fibrosis (CF).. 332
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF) Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology Year: 2008
Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements Source: Eur Respir J 2002; 20: Suppl. 38, 20s Year: 2002
Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001
Variability of multiple breath washout (MBW) assessment of functional residual capacity (FRC) in cystic fibrosis (CF) patients using an ultrasonic device Source: Eur Respir J 2003; 22: Suppl. 45, 129s Year: 2003
Intestinal current measurement (ICM) as a new diagnostic test for cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation Year: 2011
Lung clearance index (LCI) and hyperinflation in children with cystic fibrosis (CF) Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012
Improved survival at low lung function in cystic fibrosis (CF) Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009
Preschool lung clearance index (LCI) predicts adolescent lung function in cystic fibrosis (CF) Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Lung clearance index (LCI) and trapped gas (TG) may reflect different aspects of Cystic Fibrosis (CF) lung disease in infants Source: Eur Respir J 2003; 22: Suppl. 45, 228s Year: 2003
Magnetic-resonance-imaging (MRI) for assessment of regional therapy response in patients with cystic fibrosis (CF) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009
Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010
Systematic review of lung clearance index (LCI) in non-cystic fibrosis (CF), non-primary ciliary dyskinesia (PCD) bronchiectasis (Bx) Source: Virtual Congress 2021 – Bronchiectasis Year: 2021
Monitoring small airways disease (SAD) in cystic fibrosis (CF) Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011
Potential utility of the N2 VC SBW test in cystic fibrosis (CF) Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017
Serial assessment of lung function in cystic fibrosis (CF) during the first years of life using the SF6 multiple breath washout (MBW) technique Source: Eur Respir J 2004; 24: Suppl. 48, 156s Year: 2004
Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF) Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles Year: 2015
The clinical utility of lung clearance index in early cystic fibrosis lung disease is not impacted by the number of multiple-breath washout trials Source: ERJ Open Res, 4 (1) 00094-2017; 10.1183/23120541.00094-2017 Year: 2018
Comparison of functional residual capacity (FRC) measured by plethysmography (FRCpleth) and multiple breath washout (FRCmbw) in schoolchildren with cystic fibrosis (CF). Source: International Congress 2018 – Respiratory physiology and measurements Year: 2018
Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
Validation of nitrogen washout (N2-WO) for measurement of lung clearance index (LCI) and functional residual capacity (FRC) in preschoolers Source: International Congress 2016 – What's new in paediatric respiratory physiology? Year: 2016